SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 82 filers reported holding SCHOLAR ROCK HLDG CORP in Q4 2022. The put-call ratio across all filers is 4.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $267,192 | -20.5% | 33,399 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $336,045 | +23.1% | 37,132 | -5.9% | 0.00% | 0.0% |
| Q3 2022 | $273,000 | -70.9% | 39,453 | -76.9% | 0.00% | -50.0% |
| Q2 2022 | $939,000 | -4.5% | 170,953 | +124.1% | 0.00% | 0.0% |
| Q1 2022 | $983,000 | +11.2% | 76,300 | +114.3% | 0.00% | 0.0% |
| Q4 2021 | $884,000 | -39.3% | 35,600 | -19.3% | 0.00% | -33.3% |
| Q3 2021 | $1,456,000 | +14.3% | 44,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,274,000 | -38.4% | 44,100 | +8.1% | 0.00% | -25.0% |
| Q1 2021 | $2,067,000 | +1.9% | 40,800 | -2.4% | 0.00% | -20.0% |
| Q4 2020 | $2,029,000 | +323.6% | 41,800 | +54.2% | 0.01% | +400.0% |
| Q3 2020 | $479,000 | -2.8% | 27,100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $493,000 | +50.3% | 27,100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $328,000 | +15.1% | 27,100 | +25.5% | 0.00% | 0.0% |
| Q4 2019 | $285,000 | +47.7% | 21,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $193,000 | -43.7% | 21,600 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $343,000 | – | 21,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |